Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts

D Ginsberg1, S I Hirai, O Pinhasi-Kimhi

  • 1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Oncogene
|April 1, 1991
PubMed

Insights

Overexpressing the c-jun gene, a key regulator, surprisingly inhibited cell transformation in experiments. This suggests enhanced c-jun activity may block cancer cell development, with the effect localized to the protein's C-terminal region.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • The c-jun gene encodes a transcriptional regulatory protein and is homologous to a viral transforming gene.
  • Understanding the biological activities of c-jun is crucial for cancer research.

Purpose of the Study:

  • To investigate the effects of mouse c-jun overproduction on cell transformation in vitro.
  • To identify the specific regions of c-jun responsible for its biological activity.

Main Methods:

  • Utilized an in vitro transformation assay using primary rat embryo fibroblasts.
  • Employed c-jun expression plasmids and deletion mutants to assess focus formation.
  • Co-transfected cells with oncogenes (ras, myc, mutant p53) and c-jun constructs.

Main Results:

  • Overproduction of c-jun did not cooperate with oncogenes like ras, myc, or mutant p53 in transformation.
  • Enhanced c-jun expression significantly inhibited focus formation induced by oncogene combinations.
  • Deletion analysis revealed that the C-terminal half of c-jun, excluding the N-terminal 187 amino acids, mediates this inhibitory activity.

Conclusions:

  • Enhanced c-jun expression can interfere with the induction and proliferation of transformed cells.
  • The inhibitory function of c-jun in this system is primarily located in its C-terminal region, specifically involving the transactivating domain and leucine repeat.